Name
Aktsiaselts Hanvar
Registry code
10413329
Type
AS - Joint Stock Company
Status
Registered
Foundation date
13.03.1998 (26)
Financial year
01.01-31.12
Capital
25 560.00 €
Activity
86221 - Provision of specialised medical treatment
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Varje Haavel 13.12.1955 (68) | 50% - 12 780.00 EUR | Board member | Direct ownership | Shareholder |
| Hannes Haavel 07.01.1954 (70) | 50% - 12 780.00 EUR | - | Direct ownership | Board memberShareholder |
| Eva Haavel 06.04.1997 (27) | - | - | Direct ownership | Board member |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Sihtasutus Ühinenud Niidu Apteegid 90004898 | - | - | - | Founder |
| 2019 23.10.2020 | 2020 02.06.2021 | 2021 01.07.2022 | 2022 28.06.2023 | |
|---|---|---|---|---|
| Total Revenue | 425 165 € | 339 975 € | 430 647 € | 426 254 € |
| Net profit (loss) for the period | -4 267 € | -50 321 € | -19 921 € | -12 471 € |
| Profit Margin | -1% | -15% | -5% | -3% |
| Current Assets | 203 769 € | 125 490 € | 124 983 € | 134 155 € |
| Fixed Assets | 287 999 € | 268 180 € | 261 828 € | 237 895 € |
| Total Assets | 491 768 € | 393 670 € | 386 811 € | 372 050 € |
| Current Liabilities | 150 968 € | 118 406 € | 145 009 € | 142 113 € |
| Non Current Liabilities | 62 045 € | 46 830 € | 33 289 € | 33 895 € |
| Total Liabilities | 213 013 € | 165 236 € | 178 298 € | 176 008 € |
| Share Capital | 25 560 € | 25 560 € | 25 560 € | 25 560 € |
| Equity | 278 755 € | 228 434 € | 208 513 € | 196 042 € |
| Employees | 7 | 8 | 9 | 10 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 24 052.78 € | 24 022.05 € | 11 |
| 2023 Q4 | - | 22 885.19 € | 22 836.76 € | 11 |
| 2023 Q3 | - | 25 009.27 € | 25 152.74 € | 12 |
| 2023 Q2 | - | 23 534.84 € | 23 557.28 € | 14 |
| 2023 Q1 | - | 20 601.35 € | 20 464.46 € | 15 |
| 2022 Q4 | - | 18 378.55 € | 18 135.54 € | 12 |
| 2022 Q3 | - | 16 128.71 € | 15 955.07 € | 12 |
| 2022 Q2 | - | 15 772.78 € | 15 520.28 € | 13 |
| 2022 Q1 | - | 16 444 € | 16 186.4 € | 13 |
| 2021 Q4 | - | 16 594.18 € | 16 359.19 € | 12 |
| 2021 Q3 | - | 16 384.94 € | 16 433.31 € | 12 |
| 2021 Q2 | - | 16 059.31 € | 16 093.12 € | 12 |
| 2021 Q1 | - | 16 291.06 € | 16 155.43 € | 12 |
| 2020 Q4 | - | 15 917.55 € | 15 824.93 € | 12 |
| 2020 Q3 | - | 12 174.95 € | 12 260.59 € | 11 |
| 2020 Q2 | - | 11 084.55 € | 10 951.58 € | 11 |
| 2020 Q1 | - | 15 530.26 € | 15 515.02 € | 11 |
